Fontaine H - Search Results

1

Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?

Pol S, Vallet-Pichard A, Fontaine H, Carrat F. Pol S, et al. Among authors: fontaine h. Liver Int. 2019 Mar;39(3):446-447. doi: 10.1111/liv.14029. Liver Int. 2019. PMID: 30793527 Free article. No abstract available.

2

Severe evolution of chronic hepatitis C in renal transplantation: a case control study.

Zylberberg H, Nalpas B, Carnot F, Skhiri H, Fontaine H, Legendre C, Kreis H, Bréchot C, Pol S. Zylberberg H, et al. Among authors: fontaine h. Nephrol Dial Transplant. 2002 Jan;17(1):129-33. doi: 10.1093/ndt/17.1.129. Nephrol Dial Transplant. 2002. PMID: 11773476

3

HCV infection and hemodialysis.

Pol S, Vallet-Pichard A, Fontaine H, Lebray P. Pol S, et al. Among authors: fontaine h. Semin Nephrol. 2002 Jul;22(4):331-9. Semin Nephrol. 2002. PMID: 12118398 Review.

4

[Atheroma and hepatitis C virus].

Vallet-Pichard A, Fontaine H, Pol S. Vallet-Pichard A, et al. Among authors: fontaine h. Gastroenterol Clin Biol. 2002 Nov;26(11):989-90. Gastroenterol Clin Biol. 2002. PMID: 12483129 Free article. French. No abstract available.

5

Veno-occlusive disease of the liver in renal transplant patients.

Vallet-Pichard A, Rerolle JP, Fontaine H, Larousserie F, Peraldi MN, Kreis H, Pol S. Vallet-Pichard A, et al. Among authors: fontaine h. Nephrol Dial Transplant. 2003 Aug;18(8):1663-6. doi: 10.1093/ndt/gfg222. Nephrol Dial Transplant. 2003. PMID: 12897112 No abstract available.

6

Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection.

Lebray P, Vallet-Pichard A, Michel ML, Fontaine H, Sobesky R, Bréchot C, Pol S. Lebray P, et al. Among authors: fontaine h. J Hepatol. 2003;39 Suppl 1:S151-9. doi: 10.1016/s0168-8278(03)00336-2. J Hepatol. 2003. PMID: 14708695 Review. No abstract available.

7

Reversibility of hepatitis C virus-related cirrhosis.

Pol S, Carnot F, Nalpas B, Lagneau JL, Fontaine H, Serpaggi J, Serfaty L, Bedossa P, Bréchot C. Pol S, et al. Among authors: fontaine h. Hum Pathol. 2004 Jan;35(1):107-12. doi: 10.1016/j.humpath.2003.08.012. Hum Pathol. 2004. PMID: 14745732

8

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.

Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Bréchot C, Michel ML. Mancini-Bourgine M, et al. Among authors: fontaine h. Hepatology. 2004 Oct;40(4):874-82. doi: 10.1002/hep.20408. Hepatology. 2004. PMID: 15382173 Clinical Trial.

9

Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C.

Fontaine H, Vallet-Pichard A, Equi-Andrade C, Nalpas B, Verkarre V, Chaix ML, Lebray P, Sobesky R, Serpaggi J, Kreis H, Pol S. Fontaine H, et al. Transplantation. 2004 Sep 27;78(6):853-7. doi: 10.1097/01.tp.0000128911.87538.aa. Transplantation. 2004. PMID: 15385804

10

The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients.

Janvier G, Chaix ML, Fontaine H, Bresson JL, Pol S, Riviere Y. Janvier G, et al. Among authors: fontaine h. Virology. 2005 Sep 30;340(2):318-25. doi: 10.1016/j.virol.2005.06.031. Virology. 2005. PMID: 16054187 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters